• 1
    The Japan Society for Oriental Medicine. Introduction to Kampo. Elsevier Japan, Tokyo, 2005.
  • 2
    Inanaga K, Dainoson K, Ninomiya Y et al. Effect of toki-shakuyaku-san in patients with senile cognitive disorders. Prog. Med. 1996; 16: 293300. (in Japanese).
  • 3
    Itoh T, Michijiri S, Murai S et al. Regulatory effect of danggui-shaoyao-san on central cholinergic nervous system dysfunction in mice. Am. J. Chin. Med. 1996; 24: 205217.
  • 4
    Toriizuka K, Hou P, Yabe T, Iijima K, Hanawa T, Cyong JC. Effects of Kampo medicine, Toki-shakuyaku-san (Tang-Kuei-Shao-Yao-San), on choline acetyltransferase activity and norepinephrine contents in brain regions, and mitogenic activity of splenic lymphocytes in ovariectomized mice. J. Ethnopharmacol. 2000; 71: 133143.
  • 5
    Ueda Y, Komatsu M, Hiramatsu M. Free radical scavenging activity of the Japanese herbal medicine toki-shakuyaku-san (TJ-23) and its effect on superoxide dismutase activity, lipid peroxides, glutamate, and monoamine metabolites in aged rat brain. Neurochem. Res. 1996; 21: 909914.
  • 6
    Song QH, Toriizuka K, Jin GB, Yabe T, Cyong JC. Long term effects of Toki-shakuyaku-san on brain dopamine and nerve growth factor in olfactory-bulb-lesioned mice. Jpn J. Pharmacol. 2001; 86: 183188.
  • 7
    Egashira N, Iwasaki K, Akiyoshi Y et al. Protective effect of Toki-shakuyaku-san on amyloid beta25–35-induced neuronal damage in cultured rat cortical neurons. Phytother. Res. 2005; 19: 450453.
  • 8
    Winblad B, Palmer K, Kivipelto M et al. Mild cognitive impairment–beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med. 2004; 256: 240246.
  • 9
    Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J. Nucl. Med. 1995; 36: 12381248.